Show simple item record

dc.contributor.authorGovaerts, Laurenz
dc.contributor.authorGeldof, Tine
dc.contributor.authorSimoens, Steven
dc.contributor.authorHuys, Isabelle
dc.date.accessioned2018-01-23T14:37:23Z
dc.date.available2018-01-23T14:37:23Z
dc.date.issued2017
dc.identifier.issn1098-3015
dc.identifier.doi10.1016/j.jval.2017.08.1586
dc.identifier.urihttp://hdl.handle.net/20.500.12127/5898
dc.description.abstractNew co-development approaches in personalized medicine challenge current decisional frameworks of health-technology access and reimbursement procedures. We aim to conceptualize an efficient typology-based decisional framework which takes into account the development and market access synchronism between therapeutic (Tx) and diagnostic (Dx) components of personalized medicines.
dc.language.isoen
dc.publisherBlackwell Pub.
dc.subjectHealthcare
dc.subjectClinical Pharmacology
dc.subjectPharmacotherapy
dc.titleA typology-based decisional framework to support market access and reimbursement decisions for personalised medicines
dc.identifier.journalValue in Health. The Journal of the International Society for Pharmacoeconomics and Outcomes Research
dc.source.volume20
dc.source.issue9
dc.source.beginpageA661
dc.source.endpageA661
dc.contributor.departmentKU Leuven
dc.identifier.eissn1524-4733
vlerick.knowledgedomainSpecial Industries : Healthcare Management
vlerick.typearticleJournal article
vlerick.vlerickdepartmentTOM
dc.identifier.vperid176581
dc.identifier.vperid31183


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record